Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
Both chronic myeloid leukemia and acute myeloid leukemia evade the immune response during their development and disease progression. As myeloid leukemia cells modify their bone marrow microenvironment, they lead to dysfunction of cytotoxic cells, such as CD8+ T cells or NK cells, simultaneously prom...
Main Authors: | Julian Swatler, Laura Turos-Korgul, Ewa Kozlowska, Katarzyna Piwocka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/6/1203 |
Similar Items
-
What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by: Marco Pizzi, et al.
Published: (2023-03-01) -
Acute Myeloid Leukemia: analysis of epidemiological profile and survival rate
by: Mariana Cardoso de Lima, et al.
Published: (2016-05-01) -
A Case of Leukemia Cutis with Acute Myeloid Leukemia on Azacitidine Therapy
by: Asude Kara, et al.
Published: (2017-05-01) -
Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles
by: Heide-Marie Binder, et al.
Published: (2021-11-01) -
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
by: Carolina Alarcón-Payer, et al.
Published: (2022-09-01)